Portland Global Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Portland Global Advisors's GILD Position: Q4 2020 in Review
Portland Global Advisors sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 3,478 shares — an estimated $220K sold.
Portland Global Advisors first reported a position in GILD in Q1 2014 and held it in 27 quarters. The position peaked at $828K in Q1 2018. 1,564 funds tracked by Wall St. Rank hold GILD as of Q4 2020.
- Portland Global Advisors reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
- Portland Global Advisors sold 3,478 Gilead Sciences shares in Q4 2020, an estimated $220K.
- Portland Global Advisors first reported a position in Gilead Sciences in Q1 2014 and held it in 27 quarters.
- Portland Global Advisors's Gilead Sciences position peaked at $828K in Q1 2018.
- 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.
Based on Portland Global Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.